Literature DB >> 27320519

Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?

Maram Isaac1, Kamiar Mireskandari2, Nasrin Tehrani3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27320519     DOI： 10.1016/j.ophtha.2016.04.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  1 in total

1.  Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression.

Authors:  Aslı Vural; Dilbade Yıldız Ekinci; Ismail Umut Onur; Gülsüm Oya Hergünsel; Fadime Ulviye Yiğit
Journal:  Int Ophthalmol       Date:  2019-01-02       Impact factor: 2.031
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.